EVAN ROSEN LAB

Our research is focused on the transcriptional pathways that underlie metabolic diseases like obesity and Type 2 diabetes. In particular, we have a longstanding interest in using genomic and epigenomic approaches to identify novel transcription factors and pathways that regulate processes such as adipogenesis, lipid handling, insulin resistance, and metabolic memory. Our ultimate goal is to define novel targets that can be manipulated to improve outcomes in metabolic disease.

Primary location: Boston United States